RAPT Therapeutics (RAPT) Current Assets: 2020-2023
Historic Current Assets for Therapeutics (RAPT) over the last 4 years, with Dec 2023 value amounting to $161.8 million.
- Therapeutics' Current Assets fell 45.18% to $102.6 million in Q3 2024 from the same period last year, while for Sep 2024 it was $102.6 million, marking a year-over-year decrease of 45.18%. This contributed to the annual value of $161.8 million for FY2023, which is 35.98% down from last year.
- Per Therapeutics' latest filing, its Current Assets stood at $161.8 million for FY2023, which was down 35.98% from $252.7 million recorded in FY2022.
- Therapeutics' 5-year Current Assets high stood at $252.7 million for FY2022, and its period low was $115.6 million during FY2020.
- In the last 3 years, Therapeutics' Current Assets had a median value of $193.0 million in 2021 and averaged $202.5 million.
- As far as peak fluctuations go, Therapeutics' Current Assets surged by 66.93% in 2021, and later crashed by 35.98% in 2023.
- Over the past 4 years, Therapeutics' Current Assets (Yearly) stood at $115.6 million in 2020, then skyrocketed by 66.93% to $193.0 million in 2021, then surged by 30.95% to $252.7 million in 2022, then plummeted by 35.98% to $161.8 million in 2023.